Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 387 | N/A | N/A | 0 | N/A |
| Receivables | 115 | N/A | N/A | 0 | N/A |
| Inventories | 260 | N/A | N/A | 0 | N/A |
| TOTAL | $992 | $N/A | $N/A | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 253 | N/A | N/A | 0 | N/A |
| TOTAL | $253 | $N/A | $N/A | $0 | $N/A |
| Total Assets | $1,245 | $N/A | $N/A | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 100 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 8,625 | N/A | N/A | 0 | N/A |
| Other current liabilities | 87 | N/A | N/A | 0 | N/A |
| TOTAL | $8,825 | $N/A | $N/A | $0 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $0 | $N/A |
| Total Liabilities | $8,825 | $N/A | $N/A | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,724 | N/A | N/A | 8,142 | N/A |
| Common Shares | 7 | N/A | N/A | 0 | N/A |
| Retained earnings | -32,332 | N/A | N/A | 0 | N/A |
| TOTAL | $-7,580 | $N/A | $N/A | $0 | $N/A |
| Total Liabilities And Equity | $1,245 | $0 | $0 | $0 | $0 |